COVID-19 Policies
Issuance Date Title
Department Memorandum 2022-0041 January 24, 2022 Interim guidelines on the management and administration of Tozinameran COVID-19 mRNA vaccine (nucleoside-modified) [Cominarty] Pfizer COVID-19 vaccine to pediatric population ages 5-11 years old
Joint Memorandum Circular 2022-0001 January 20, 2022 Operational Guidelines for the Loaning of COVID-19 Vaccine Doses Between the National Government, Local Government Units, and Private Sector Entities
Department Circular 2022-0064 January 17, 2022 Adjustments in Maximum Retail Price (MRP) regulation of certain medicines that are covered by Executive Order No. 155 pursuant to exemption from Value Added Tax (VAT)
Department Memorandum 2022-0013 January 14, 2022 Updated Guidelines on Quarantine, Isolation, and Testing for COVID-19 Response and Case Management for the Omicron Variant
Joint Memorandum Circular No. 22-01 January 10, 2022 Setting of purchase limit/cap for Paracetamol, Phenylephrinehydochloride, Carbocisteine, and Chlorphenamine Maleate Paracetamol
Department Circular 2022-0002 January 06, 2022 Advisory on COVID-19 Protocols for Quarantine and Isolation
Department Memorandum 2021-0492-A December 01, 2021 Amendment to DM No. 2021-0492: Interim Guidelines on the Administration and Management of COVID-19 Vaccine Booster/Additional Doses to Priority Group A2: Senior Citizens ages 60 years old & above and Priority Group A3...
Department Memorandum 2021-0492 November 19, 2021 Interim Guidelines on the Administration and Management of COVID-19 Vaccine Booster/ Additional Doses to Priority Group A2: Senior Citizen ages 60 years old and above and Priority A3: Adults with Comorbidities
Department Circular 2021-0525 November 16, 2021 Reiteration of the Interim Operational Guidelines on the Administration of COVID-19 Vaccine Booster Dose to Priority Group A1: Essential Workers in Frontline Health Services (A1.1 to A1.7)
Department Circular 2021-0464 October 14, 2021 Interim Operational Guidelines on the COVID-19 Vaccination of the Pediatric Population Ages 12-17 Years Old with Comorbidities
Joint Memorandum Circular 2021-0001-A September 23, 2021 Amendment of Joint Memorandum Circular of DOH-DTI-DOLE-DILG-DOTr-PSC-GAB entitled "Clarificatory Guidelines on the Mandatory Use of Face Shields Outside of Residence for COVID-19 Mitigation"
Department Circular 2021-0396 September 01, 2021 Reiteration of Department Circular No. 2021-0323 on price cap for COVID-19 Rapid Antigen Testing

Pages